CT7001

· Carrick Therapeutics Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CT7001, covering 2025-11-12 to 2026-06-23. Get the full timeline:

Most recent: Clinical Trial Results: Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies [Phase 1, Phase 2]